Last reviewed · How we verify
NCT06972342: Fit&Active
Fit & Active Retirement: A Physical Function Programme for Young-old Retirees
NA trial testing education in Healthy in 300 participants. Participants enrolled and being followed up; not accepting new ones.
31 May 2025
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 1 April 2023 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 May 2025 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- education
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Chinese University of Hong Kong
Who can join
Adults 55 to 70, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical inactivity is the fourth leading cause of mortality in the world; as such, the World Health Organization (WHO) recommends that adults engage in at least 150 minutes of moderate-intensity physical activity every week. In addition, the WHO further recommends that older adults (i.e., those 65 years or above) engage in activities that promote functional balance and muscular strength to reduce the risks of falls. This is important because falls are the leading cause of injury-related deaths among older adults. Research has also shown that having good physical function (i.e., activity level, balance, and strength) is associated with better health, well-being, and quality of life. As suggested by results from the Hong Kong Health Behaviour Survey 2018/19, older adults in Hong Kong are generally active, with 85% of the population doing more than 150 minutes of activity on a weekly basis. The survey, however, did not include questions about whether respondents engaged in functional balance training. The above figures suggest that older adults may be unaware of the importance of functional balance and strength training and may not be attaining their optimal levels of physical function. Our proposed study aims to address this issue by delivering an intervention program aimed at increasing retirees' physical activity levels, with emphasis placed on functional balance and muscular strength training. Retirees in Hong Kong are generally healthy, active, and capable of self-learning and self-regulation. Provision of knowledge and support could lead to positive behavior change. Also, as mobile-based messaging (e.g., WhatsApp) has become mainstream, retirees have a good level of competence in using mobile phones as a means of communication. This mode of communication has become increasingly important since face-to-face contact could be impeded by pandemic-led social distancing. Therefore, the proposed project will be delivered primarily through e-platforms. Our previous work has shown that adults' behaviors and attitudes could be enhanced through an internet-based program. Preliminary results of our ongoing retiree-focused program also suggest that older adults are receptive to mobile-based interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06972342
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of education
Trials testing the same drug.
- NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
- NCT07471412 — Sexually Transmitted Infections in Migrant Women · NA · not yet recruiting
- NCT07289672 — Food Limitations In Crohn's Disease and Ulcerative coliTis · NA · not yet recruiting
- NCT07247903 — The Impact of Patient Education Delivered Through Virtual Reality · NA · not yet recruiting
- NCT07383792 — Effect of BMT Educational Guidelines on Nurses' Skills · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06972342 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06972342.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing